Pharsight

1. Drug name - COLAZAL

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7625884	VALEANT PHARMS INTL	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives	Aug, 2026 (3 years from now)
US7452872	VALEANT PHARMS INTL	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives	Aug, 2026 (3 years from now)
US7452872 (Pediatric)	VALEANT PHARMS INTL	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives	Feb, 2027 (4 years from now)
US7625884 (Pediatric)	VALEANT PHARMS INTL	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives	Feb, 2027 (4 years from now)

Treatment: Treatment of ulcerative colitis

Dosage: CAPSULE;ORAL

Strength	Dosage	Availability
750MG	CAPSULE;ORAL	Prescription

2. Drug name - GIAZO

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9192616	VALEANT PHARMS INTL	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives	Aug, 2026 (3 years from now)
US7625884	VALEANT PHARMS INTL	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives	Aug, 2026 (3 years from now)
US7452872	VALEANT PHARMS INTL	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives	Aug, 2026 (3 years from now)
US8497256	VALEANT PHARMS INTL	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males	Jun, 2031 (8 years from now)

Treatment: Treatment of mildly to moderately active ulcerative colitis in male patients

Dosage: TABLET;ORAL

Strength	Dosage	Availability
1.1GM	TABLET;ORAL	Discontinued

availability in other generic markets.

Click on the highlighted region to filter.